Celikel, E. Et Al. 2022. Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.28, no.2 .

Celikel, E., Tekin, Z. E., Aydin, F., EMEKSİZ, S., Uyar, E., Ozcan, S., ... Perk, O.(2022). Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.28, no.2.

Celikel, Elif Et Al. "Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children," JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.28, no.2, 2022

Celikel, Elif Et Al. "Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children." JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.28, no.2, 2022

Celikel, E. Et Al. (2022) . "Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children." JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.28, no.2.

@article{article, author={Elif Celikel Et Al. }, title={Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children}, journal={JCR-JOURNAL OF CLINICAL RHEUMATOLOGY}, year=2022}